The American biotechnology company Windtree Therapeutics has announced a significant entry into the cryptocurrency market, planning to invest up to $700 million in acquiring BNB – the native cryptocurrency of the BNB Chain ecosystem.
This is reported by Business • Media
Financial agreements to expand the crypto portfolio
According to the company, two financial agreements have been signed totaling up to $520 million to implement this strategy. The first will be the opening of a credit line (ELOC) of up to $500 million through the sale of common shares of Windtree Therapeutics. Additionally, a contract for $20 million has been signed with Build and Build Corp. All these funds will be directed towards purchasing BNB, and according to official information, 99% of the raised investments will go specifically to this asset.
“We are excited to implement these new tools for future BNB acquisitions as part of our crypto-holding strategy. Subject to shareholder approval, the ability to raise additional funds for purchasing BNB is crucial to our strategy,” commented Windtree CEO Jed Latkin.
Asset diversification and market support
It is worth noting that the company will only be able to utilize the credit line (ELOC) after shareholders approve the decision to increase the number of issued common shares. Windtree Therapeutics explains this move as a desire to diversify its portfolio by investing in digital assets with high growth potential.
Windtree’s partner in this initiative is Build and Build Corp, founded by financiers Patrick Horsman, Joshua Kruger, and Jonathan Pash. The company is also receiving support from leading market participants such as Kraken, Galaxy Digital, Off The Chain Capital, and others.
Build and Build Corp Director Patrick Horsman emphasized that Windtree’s strategy of integrating BNB into corporate reserves is a progressive approach to enhancing the company’s value.
As a reminder, BNB recently reached an all-time high when its price exceeded $800, marking a record for this cryptocurrency.